학술논문

Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors
Document Type
Article
Source
In: Molecular Cancer Therapeutics. (Molecular Cancer Therapeutics, July 2022, 21(7):1047-1059)
Subject
Language
English
ISSN
15388514
15357163